Dr. Gaston De Serres is an epidemiologist practitioner at the l’Institut national de santé publique du Québec and a regular researcher in the Infectious and Immune Disease Axis at the CHU de Québec-Laval University. He is a full professor in epidemiology in the Department of social and preventive medicine at Laval University where he has been teaching since 1997. He is chief physician of the scientific immunization group (SIG) of the Institut national de santé publique du Québec and an active member of the Comité sur l’immunisation du Québec (CIQ).

Dr. De Serre works on the control and prevention of infectious diseases, with a focus on diseases that are avoidable through vaccination and on respiratory diseases. His research work is on the epidemiology of diseases that are preventable through vaccination and the efficacy of vaccinations used in routine programs, and in particular, on the efficacy of the influenza vaccine.

2400, avenue d'Estimauville, 3e étage
Québec, Québec
Canada G1E 7G9
+1 418-650-5115, extension 6274
+1 418-666-2776
gaston.de-serres@crchudeq... Gaston.DeSerres@inspq.qc....

Latest news

340 entries « ‹ 1 of 34 › »

Skowronski DM, De Serres G

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Journal Article

N Engl J Med, 384 (11), 2021, ISSN: 0028-4793.

| Links:

Longtin Y, Charest H, Quach C, Savard P, Baz M, Boivin G, Farfard J, Villeneuve J, Roger M, De Serres G

Infectivity of healthcare workers diagnosed with coronavirus disease 2019 (COVID-19) approximately 2 weeks after onset of symptoms: A cross-sectional study.

Journal Article

Infect Control Hosp Epidemiol, pp. 1-3, 2021, ISSN: 0899-823X.

Abstract | Links:

Ducrocq J, Simon A, Lemire M, De Serres G, Levesque B

Exposure to Toxoplasma gondii Through Consumption of Raw or Undercooked Meat: A Systematic Review and Meta-Analysis.

Journal Article

Vector Borne Zoonotic Dis, 21 (1), pp. 40-49, 2021, ISSN: 1530-3667.

Abstract | Links:

Gilca R, Billard MN, Zafack J, Papenburg J, Boucher FD, Charest H, Rochette M, De Serres G

Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada.

Journal Article

Prev Med Rep, 20 , pp. 101180, 2020, ISSN: 2211-3355.

Abstract | Links:

Skowronski DM, Zou M, Clarke Q, Chambers C, Dickinson JA, Sabaiduc S, Olsha R, Gubbay JB, Drews SJ, Charest H, Winter AL, Jassem A, Murti M, Krajden M, De Serres G

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017.

Journal Article

Clin Infect Dis, 71 (16), pp. 2285-2288, 2020, ISSN: 1058-4838.

Abstract | Links:

Gilca R, Carazo S, Amini R, Charest H, De Serres G

Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Quebec, Canada.

Journal Article

J Infect Dis, 2020, ISSN: 0022-1899.

Abstract | Links:

Ahmed MA, Naus M, Singer J, Valiquette L, Coleman BL, De Serres G, Vanderkooi OG, Top KA, Isenor JE, Kellner JD, McCarthy AE, Bettinger JA, Canadian Immunization Research Network (CIRN)

Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13-2016/17, the Canadian Vaccine Safety Network.

Journal Article

Vaccine, 38 (19), pp. 3582-3590, 2020, ISSN: 0264-410X.

Abstract | Links:

Carazo S, Billard MN, Boutin A, De Serres G

Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.

Journal Article

BMC Infect Dis, 20 (1), pp. 251, 2020.

Abstract | Links:

Skowronski DM, Leir S, Sabaiduc S, Chambers C, Zou M, Rose C, Olsha R, Dickinson JA, Winter AL, Jassem A, Gubbay JB, Drews SJ, Charest H, Chan T, Hickman R, Bastien N, Li Y, Krajden M, De Serres G

Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.

Journal Article

J Infect Dis, 2020, ISSN: 0022-1899.

Abstract | Links:

Sauvageau C, Panicker G, Unger ER, De Serres G, Schiller J, Ouakki M, Gilca V

Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials.

Journal Article

Hum Vaccin Immunother, 16 (3), pp. 590-594, 2020.

Abstract | Links:

340 entries « ‹ 1 of 34 › »
Signaler des ajouts ou des modifications

Active projects

  • (CV04 QC03) CANVAS Network - Surveillance of adverse events following immunization among children and adults immunized with the influenza vaccine, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2017-06-01 to 2022-03-31
  • (SI03 QC03) Special Immunization Clinic Network (SIC) to investigate vaccine safety issues: Optimizing the clinical management of patients with contraindication to vaccination ..., Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2019-04-01 to 2022-03-31
  • Canadian Immunization Research Network, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2014-06-01 to 2021-12-31
  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31

Recently finished projects

  • Capacité du vaccin ... à induire des niveaux protecteurs d'anticorps contre l'influenza B de la lignée Victoria chez des enfants initialement immunisés 9 ans auparavant avec des doses de vaccins contenant la lignée Yamagata (TITER III), Subvention, Ministère de la Santé et des Services sociaux, from 2019-01-15 to 2019-12-31
  • Interchangeabilité des vaccins VPH., Subvention, Ministère de la Santé et des Services sociaux, from 2011-03-29 to 2019-12-31
Data provided by the Université Laval research projects registery